CME Group Berhad Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 2/6

CME Group Berhad şirketinin toplam hissedar öz sermayesi MYR49.2M ve toplam borcu MYR32.6M olup, bu da borç-öz sermaye oranını 66.4% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla MYR103.0M ve MYR53.8M dir.

Anahtar bilgiler

66.4%

Borç/özkaynak oranı

RM 32.64m

Borç

Faiz karşılama oranı	n/a
Nakit	RM 6.15m
Eşitlik	RM 49.19m
Toplam yükümlülükler	RM 53.78m
Toplam varlıklar	RM 102.98m

Son finansal sağlık güncellemeleri

Recent updates

Is CME Group Berhad (KLSE:CME) Using Too Much Debt?

Sep 30

Is CME Group Berhad (KLSE:CME) Using Debt In A Risky Way?

Jun 08

CME Group Berhad (KLSE:CME) Has Debt But No Earnings; Should You Worry?

Sep 26

Is CME Group Berhad (KLSE:CME) Using Debt In A Risky Way?

Jun 02

Is CME Group Berhad (KLSE:CME) Using Debt Sensibly?

Feb 17

CME Group Berhad (KLSE:CME) Has Debt But No Earnings; Should You Worry?

Aug 17

CME Group Berhad (KLSE:CME) Is Carrying A Fair Bit Of Debt

May 03

Is CME Group Berhad (KLSE:CME) A Risky Investment?

Jan 17

Is CME Group Berhad (KLSE:CME) A Risky Investment?

Sep 22

Would CME Group Berhad (KLSE:CME) Be Better Off With Less Debt?

Jun 02

Here's Why CME Group Berhad (KLSE:CME) Has A Meaningful Debt Burden

Feb 17

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: CME 'nin kısa vadeli varlıkları ( MYR25.3M ) kısa vadeli yükümlülüklerini ( MYR51.2M ) kapsamıyor.

Uzun Vadeli Yükümlülükler: CME şirketinin kısa vadeli varlıkları ( MYR25.3M ) uzun vadeli yükümlülüklerini ( MYR2.6M ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: CME 'nin net borç/öz sermaye oranı ( 53.9% ) yüksek olarak değerlendiriliyor.

Borcun Azaltılması: CME 'nin borç/öz sermaye oranı son 5 yılda 88.9% seviyesinden 66.4% seviyesine düştü.

Bilanço

Nakit Pist Analizi

Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.

İstikrarlı Nakit Pisti: CME şirketinin mevcut serbest nakit akışına dayanarak yeterli nakit pistine sahip olup olmadığını belirlemek için yeterli veri yok.

Tahmini Nakit Akışı: CME tarihsel oranlara göre serbest nakit akışı büyümeye veya küçülmeye devam ederse yeterli nakit pistine sahip olup olmadığını belirlemek için yeterli veri yok.

CME Group Berhad Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 2/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Is CME Group Berhad (KLSE:CME) Using Too Much Debt?

Is CME Group Berhad (KLSE:CME) Using Debt In A Risky Way?

CME Group Berhad (KLSE:CME) Has Debt But No Earnings; Should You Worry?

Is CME Group Berhad (KLSE:CME) Using Debt In A Risky Way?

Is CME Group Berhad (KLSE:CME) Using Debt Sensibly?

CME Group Berhad (KLSE:CME) Has Debt But No Earnings; Should You Worry?

Recent updates

Is CME Group Berhad (KLSE:CME) Using Too Much Debt?

Third quarter 2024 earnings released: RM0.001 loss per share (vs RM0 in 3Q 2023)

Is CME Group Berhad (KLSE:CME) Using Debt In A Risky Way?

New major risk - Financial position

Second quarter 2024 earnings released: RM0.001 loss per share (vs RM0.001 loss in 2Q 2023)

First quarter 2024 earnings released: EPS: RM0.001 (vs RM0 in 1Q 2023)

CME Group Berhad, Annual General Meeting, Mar 20, 2024

Full year 2023 earnings released: RM0.001 loss per share (vs RM0.005 loss in FY 2022)

CME Group Berhad Announces Appointment of Ym Tengku Munawirah Putra as Independent Director

CME Group Berhad has filed a Follow-on Equity Offering in the amount of MYR 3.60561 million.

Full year 2023 earnings released: RM0.001 loss per share (vs RM0.005 loss in FY 2022)

CME Group Berhad (KLSE:CME) Has Debt But No Earnings; Should You Worry?

CME Group Berhad Announces Redesignation of Miss Ong Suan Pin from Non Independent and Non Executive Director

Third quarter 2023 earnings released: RM0.001 loss per share (vs RM0 in 3Q 2022)

Is CME Group Berhad (KLSE:CME) Using Debt In A Risky Way?

CME Group Berhad Announces the Resignation of Encik Reza Bin Shariffudin as Independent and Non-Executive Chairman of the Nomination Committee

Second quarter 2023 earnings released: EPS: RM0 (vs RM0 in 2Q 2022)

Is CME Group Berhad (KLSE:CME) Using Debt Sensibly?

CME Group Berhad, Annual General Meeting, Dec 15, 2022

First quarter 2023 earnings released: RM0.001 loss per share (vs RM0.001 loss in 1Q 2022)

CME Group Berhad Announces Resignation of Setia Tengku Indera Pahlawan Tengku Putra Alhaj Bin Tengku Azman Shah Alhaj as Independent and Non Executive Chairman of Remuneration Committee

Insufficient new directors

Full year 2022 earnings released: RM0.005 loss per share (vs RM0.003 profit in FY 2021)

Full year 2022 earnings released: RM0.005 loss per share (vs RM0.003 profit in FY 2021)

CME Group Berhad (KLSE:CME) Has Debt But No Earnings; Should You Worry?

Third quarter 2022 earnings released: EPS: RM0 (vs RM0.001 loss in 3Q 2021)

CME Group Berhad (KLSE:CME) Is Carrying A Fair Bit Of Debt

Insufficient new directors

CME Group Berhad Announces Kuala Lumpur High Court Dismisses the Originating Summons for Fortuna Injunction

CME Group Berhad Announces Update on Writ of Summon and Statement of Claim Filed by Bellajade Sdn Bhd

CME Group Berhad Announces Resignation of Gerard Thavanesan A/L Nicholas Paulian as Chief Operating Officer

CME Group Berhad Provides Update on Material Litigation

Second quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Is CME Group Berhad (KLSE:CME) A Risky Investment?

CME Group Berhad Provides Update on Material Litigation

Is CME Group Berhad (KLSE:CME) A Risky Investment?

Would CME Group Berhad (KLSE:CME) Be Better Off With Less Debt?

Third quarter 2021 earnings released: RM0.001 loss per share (vs RM0.001 profit in 3Q 2020)

Here's Why CME Group Berhad (KLSE:CME) Has A Meaningful Debt Burden

CME Group Berhad Provides Update on Litigation

CME Group Berhad Announces Appointment of Yap Wai Yee as Chief Executive Officer

CME Group Berhad Announces the Re-designation of Tengku Indera Pahlawan Tengku Putra Alhaj Bin Tengku Azman Shah Alhaj from Independent and Non Executive Member of Nomination Committee to Chairman of Nomination Committee

CME Group Berhad Announces the Demise of Dato' Khairi Bin Mohamad, Independent and Non Executive Chairman of Remuneration Committee

CME Group Berhad Updates on Its Lawsuits

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Nakit Pist Analizi

Sağlıklı şirketleri keşfedin